These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 24094579

  • 1. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways.
    Giuliani D, Bitto A, Galantucci M, Zaffe D, Ottani A, Irrera N, Neri L, Cavallini GM, Altavilla D, Botticelli AR, Squadrito F, Guarini S.
    Neurobiol Aging; 2014 Mar; 35(3):537-47. PubMed ID: 24094579
    [Abstract] [Full Text] [Related]

  • 2. Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer׳s disease.
    Giuliani D, Galantucci M, Neri L, Canalini F, Calevro A, Bitto A, Ottani A, Vandini E, Sena P, Sandrini M, Squadrito F, Zaffe D, Guarini S.
    Eur J Pharmacol; 2014 Oct 05; 740():144-50. PubMed ID: 25034807
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of cerebral ischemia with melanocortins acting at MC4 receptors induces marked neurogenesis and long-lasting functional recovery.
    Giuliani D, Zaffe D, Ottani A, Spaccapelo L, Galantucci M, Minutoli L, Bitto A, Irrera N, Contri M, Altavilla D, Botticelli AR, Squadrito F, Guarini S.
    Acta Neuropathol; 2011 Oct 05; 122(4):443-53. PubMed ID: 21927944
    [Abstract] [Full Text] [Related]

  • 6. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK, Kim HG, Baek SH, Jung WR, Park DI, Park JS, Jo DG, Kim KL.
    Neurobiol Aging; 2014 May 05; 35(5):990-1001. PubMed ID: 24268884
    [Abstract] [Full Text] [Related]

  • 7. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D, Curcio M, Canzoniero LM, Navarra R, Lattanzio R, Piantelli M, Sensi SL.
    Neurobiol Dis; 2015 Sep 05; 81():214-24. PubMed ID: 25434488
    [Abstract] [Full Text] [Related]

  • 8. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Sep 05; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 9. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
    Bitto A, Giuliani D, Pallio G, Irrera N, Vandini E, Canalini F, Zaffe D, Ottani A, Minutoli L, Rinaldi M, Guarini S, Squadrito F, Altavilla D.
    Inflamm Res; 2017 May 05; 66(5):389-398. PubMed ID: 28238167
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of the canonical Wnt-3A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia.
    Spaccapelo L, Galantucci M, Neri L, Contri M, Pizzala R, D'Amico R, Ottani A, Sandrini M, Zaffe D, Giuliani D, Guarini S.
    Eur J Pharmacol; 2013 May 05; 707(1-3):78-86. PubMed ID: 23535605
    [Abstract] [Full Text] [Related]

  • 11. Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268.
    Giuliani D, Ottani A, Minutoli L, Stefano VD, Galantucci M, Bitto A, Zaffe D, Altavilla D, Botticelli AR, Squadrito F, Guarini S.
    Brain Behav Immun; 2009 Aug 05; 23(6):844-50. PubMed ID: 19345727
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X, Ren X, Huang P, Li S, Ma Q, Ying M, Ni J, Liu J, Yang X.
    J Alzheimers Dis; 2014 Aug 05; 40(3):575-86. PubMed ID: 24496070
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease.
    Liu S, Tang SQ, Cui HJ, Yin S, Yin M, Zhao H, Meng LH, Wang ZJ, Lu Y.
    J Pharmacol Sci; 2016 Sep 05; 132(1):92-99. PubMed ID: 27671351
    [Abstract] [Full Text] [Related]

  • 18. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Sep 05; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 19. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W, Saul A, Kacza J, Grosche J, Goldhammer S, Michalski D, Wirths O.
    Neuropathol Appl Neurobiol; 2014 Feb 05; 40(2):106-20. PubMed ID: 23566195
    [Abstract] [Full Text] [Related]

  • 20. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G, Zhang Z, Wen L, Chen C, Shi Q, Zhang Y, Ni J, Liu Q.
    J Alzheimers Dis; 2014 Feb 05; 41(1):85-99. PubMed ID: 24577479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.